James G Jackson

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum Stress

Top Venues

Cancer metastasis reviews

Breast cancer research : BCR

The Journal of cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Fang-Yen Chiu, Raegan M Kvadas, Zeinab Mheidly, Ashkan Shahbandi, James G Jackson
Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer metastasis reviews (2023)
Fang-Yen Chiu, Raegan M Kvadas, Zeinab Mheidly, Ashkan Shahbandi, James G Jackson
Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer metastasis reviews 42 (1) (2023)
Fang-Yen Chiu, Raegan M Kvadas, Zeinab Mheidly, Ashkan Shahbandi, James G Jackson
Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer metastasis reviews 42 (1) (2023)
Fang-Yen Chiu, Raegan M Kvadas, Zeinab Mheidly, Ashkan Shahbandi, James G Jackson
Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer metastasis reviews 42 (1) (2023)
Fang-Yen Chiu, Raegan M Kvadas, Zeinab Mheidly, Ashkan Shahbandi, James G Jackson
Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer metastasis reviews 42 (1) (2023)
Wesley D Frey, Ashlyn Y Anderson, Hyemin Lee, Julie B Nguyen, Emma L Cowles, Hua Lu, James G Jackson
Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells. PLoS biology 20 (10) (2022)
Ashkan Shahbandi, Fang-Yen Chiu, Nathan A Ungerleider, Raegan Kvadas, Zeinab Mheidly, Meijuan J S Sun, Di Tian, Daniel A Waizman, Ashlyn Y Anderson, Heather L Machado, Zachary F Pursell, Sonia G Rao, James G Jackson
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nature cancer (2022)
Ashkan Shahbandi, Sonia G Rao, Ashlyn Y Anderson, Wesley D Frey, Joie O Olayiwola, Nathan A Ungerleider, James G Jackson
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer. Cell death and differentiation 27 (11) (2020)
Crystal A Tonnessen-Murray, James G Jackson
Engulfment and cannibalism drive persistence of chemotherapy-treated tumor cells: can they be targeted? Molecular & cellular oncology 7 (1) (2019)
Crystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, Ashkan Shahbandi, Nathan A Ungerleider, Joie O Olayiwola, Lucas B Murray, Benjamin T Vinson, Douglas B Chrisey, Christopher J Lord, James G Jackson
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival. The Journal of cell biology 218 (11) (2019)
Nathan A Ungerleider, Sonia G Rao, Ashkan Shahbandi, Douglas Yee, Tianhua Niu, Wesley D Frey, James G Jackson
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment. Breast cancer research : BCR 20 (1) (2018)